Future Medicine

SHERPA: White

People

  1. Motzer
    Motzer
  2. Slovin
    Slovin
  3. Bajorin
    Bajorin
  4. Rosenberg
    Rosenberg
  5. Feldman
    Feldman
  6. Iyer
    Iyer
  7. Rathkopf
    Rathkopf
  8. Sternschuss
    Sternschuss
  9. Voss
    Voss

Groups

  1. Department of Medicine (18)
  2. Genitourinary Oncology Service (18)
  3. Solid Tumor Oncology Division (18)
  4. Hematologic Malignancies, Division of (4)
Search Within
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (9)
  2. Review (5)
  3. Editorial (4)
Groups
  1. Department of Medicine (18)
  2. Genitourinary Oncology Service (18)
  3. Solid Tumor Oncology Division (18)
  4. Hematologic Malignancies, Division of (4)
People
  1. Robert Motzer (6)
  2. Susan Slovin (4)
  3. Dean Bajorin (2)
  4. Jonathan Rosenberg (2)
  5. Andrea Apolo (1)
  6. Dana Rathkopf (1)

More People

Years
  1. 2025 (5)
  2. 2024 (1)
  3. 2023 (3)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Future Oncology (14)
  2. Immunotherapy (3)
  3. Biomarkers in Medicine (1)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma
    Journal Article

    Murphy, D. A.; Rini, B. I.; Escudier, B.; Motzer, R. J.; Wang, P.; Li, S.; Williams, J. A.; Tarazi, J. C.; Martini, J. F.
    Future Oncology (2020)

    Fulltext@MSK | Save
  • The challenge of checkpoint inhibitors in prostate cancer: Drugs for the many but useful to a few
    Editorial

    Slovin, S. F.
    Immunotherapy (2020)

    Fulltext@MSK | Save
  • Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: Study design and rationale
    Journal Article

    Grünwald, V.; Powles, T.; Choueiri, T. K.; Hutson, T. E.; Porta, C.; Eto, M.; Sternberg, C. N.; Rha, S. Y.; He, C. S.; Dutcus, C. E.; more...
    Future Oncology (2019)

    Fulltext@MSK | Save
  • The need for immune biomarkers for treatment prognosis and response in genitourinary malignancies
    Journal Article

    Slovin, S. F.
    Biomarkers in Medicine (2017)

    Fulltext@MSK | Save
  • A case for the use of receiver operating characteristic analysis of potential clinical efficacy biomarkers in advanced renal cell carcinoma
    Journal Article

    English, P. A.; Williams, J. A.; Martini, J. F.; Motzer, R. J.; Valota, O.; Buller, R. E.
    Future Oncology (2016)

    Fulltext@MSK | Save
  • Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs
    Journal Article

    Slovin, S. F.
    Immunotherapy (2013)

    Fulltext@MSK | Save
  • A clinical trials outcome paradox: Should survival prevail in the absence of clinical benefit?
    Journal Article

    Slovin, S. F.
    Immunotherapy (2010)

    Fulltext@MSK | Save
  • Clinical states model for biomarkers in bladder cancer
    Journal Article

    Apolo, A. B.; Milowsky, M.; Bajorin, D. F.
    Future Oncology (2009)

    Fulltext@MSK | Save

    • Future Medicine – authorized name for: